Histotripsy Plus Chemotherapy vs Chemotherapy Alone for Advanced Colorectal Liver Metastasis

NARecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

June 30, 2025

Primary Completion Date

April 1, 2026

Study Completion Date

April 1, 2028

Conditions
Colorectal CancerLiver MetastasesLiver Cancer
Interventions
DEVICE

HistoSonics Edison® System

Histotripsy is a novel, totally non-invasive, non-ionizing, and non-thermal ablation technique that mechanically disrupts tumors through precisely controlled acoustic cavitation. Histotripsy is administered via HistoSonics Edison® System.

DRUG

Chemotherapy

Chemotherapy (standard of care with first line therapy of base of 5-FU with either oxaliplatin or irinotecan).

Trial Locations (1)

44195

RECRUITING

Cleveland Clinic, Case Comprehensive Cancer Center, Cleveland

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

HistoSonics, Inc.

INDUSTRY

lead

Case Comprehensive Cancer Center

OTHER

NCT07044362 - Histotripsy Plus Chemotherapy vs Chemotherapy Alone for Advanced Colorectal Liver Metastasis | Biotech Hunter | Biotech Hunter